← All candidates
78 insider filings on record.
78 filings on record.
QUREuniQure N.V.
NasdaqGS · Healthcare · $3.09B
$44.51
+0.09% · Sep 11
78 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 40 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$3.09B
Float
57.5M
83% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
165.4
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
73 more transactions on Pro →Context
Wall St
$38.96 avg target
-12.5% vs today · 11 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.73 act+$0.03
Q4 '25−$0.47 act+$0.31
Q3 '25−$1.19 act−$0.45
Q2 '25−$0.60 act+$0.16
Coverage
Considering Uniqure NV (QURE) Stock? Read the AMT-130 MessageInsider Monkey · 05-20Is uniQure N.V. (QURE) A Good Stock To Buy Now?Insider Monkey · 05-13uniQure N.V. (NASDAQ:QURE) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportSimply Wall St. · 05-08uniQure Q1 Earnings Call HighlightsMarketBeat · 05-05
The file stays open
78 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice